| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K K Gnanalingham, R G Robertso. Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats--an autoradiographic study using [3H]flunitrazepam. Neuroscience. vol 57. issue 3. 1994-03-17. PMID:8309530. |
the changes in gaba receptor function implied by these results provide further insight into the pathophysiological effects of l-3,4-dihydroxyphenylalanine treatment on basal ganglia function, following dopamine denervation. |
1994-03-17 |
2023-08-12 |
human |
| A Carlsso. On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity. Journal of neural transmission. Supplementum. vol 40. 1994-03-03. PMID:7905022. |
the neuronal circuitries involving especially the basal ganglia have been extensively explored, and evidence has been presented that dopamine does not play a quite as dominant role for the initiation of movement as was formerly believed. |
1994-03-03 |
2023-08-12 |
Not clear |
| C Spyraki, S C Sealfo. Regulation of dopamine D2 receptor mRNA expression in the olfactory tubercle by cocaine. Brain research. Molecular brain research. vol 19. issue 4. 1993-12-01. PMID:8231734. |
the influence of acute and chronic cocaine treatment on the expression of dopamine d2 receptor (d2r) mrna was examined in the rat basal ganglia by in situ hybridization histochemistry. |
1993-12-01 |
2023-08-12 |
rat |
| M D Kelland, R P Soltis, R C Boldry, J R Walter. Behavioral and electrophysiological comparison of ketamine with dizocilpine in the rat. Physiology & behavior. vol 54. issue 3. 1993-11-16. PMID:8415949. |
we have compared the effects of mk 801 and ketamine on a measure of anesthesia (loss of righting reflex) and two measures of basal ganglia dopamine (da) function: apomorphine (apo)-induced stereotypy and apo-induced excitation of type ii globus pallidus (gp) neurons. |
1993-11-16 |
2023-08-12 |
rat |
| P J Langlais, L Thal, L Hansen, D Galasko, M Alford, E Maslia. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology. vol 43. issue 10. 1993-11-12. PMID:8105420. |
these reductions in basal ganglia dopamine and hva suggest that lbv cases have a level of dopamine depletion similar to parkinson's disease (pd). |
1993-11-12 |
2023-08-12 |
Not clear |
| S P Siva. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline. Neuropeptides. vol 25. issue 1. 1993-11-08. PMID:7692341. |
this study examined the influence of selected monoamine oxidase (mao) inhibitors on basal ganglia neurotransmitters (dopamine and 5-hydroxytryptamine) and neuropeptide (dynorphin) systems of sprague-dawley rats. |
1993-11-08 |
2023-08-12 |
rat |
| I J Kopi. Parkinson's disease: past, present, and future. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 9. issue 1. 1993-11-08. PMID:8397719. |
after characterization of the clinical and pathologic features of parkinson's disease, rational treatment awaited the discovery of the deficit in basal ganglia dopamine. |
1993-11-08 |
2023-08-12 |
Not clear |
| D T Blair, A Daune. Nonneuroleptic etiologies of extrapyramidal symptoms. Clinical nurse specialist CNS. vol 7. issue 4. 1993-09-16. PMID:8102320. |
dopamine blockade or depletion in the basal ganglia produces these symptoms. |
1993-09-16 |
2023-08-12 |
Not clear |
| P G Strang. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 8. issue 3. 1993-09-02. PMID:8101967. |
dopamine receptors in the basal ganglia: relevance to parkinson's disease. |
1993-09-02 |
2023-08-12 |
Not clear |
| T M Engber, J J Anderson, R C Boldry, S Kuo, T N Chas. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Neuroscience. vol 54. issue 4. 1993-09-02. PMID:8101981. |
dopamine and the excitatory amino acids play important roles in the control of motor behavior by the basal ganglia; elucidating the manner in which these transmitter systems interact may provide new therapeutic approaches to the treatment of movement disorders such as parkinson's disease. |
1993-09-02 |
2023-08-12 |
rat |
| S N Schiffmann, J J Vanderhaeghe. Caffeine regulates neurotensin and cholecystokinin messenger RNA expression in the rat striatum. Neuroscience. vol 54. issue 3. 1993-08-19. PMID:8332255. |
interactions between dopamine and neurotensin or dopamine and cholecystokinin have been demonstrated in the basal ganglia. |
1993-08-19 |
2023-08-12 |
rat |
| R M Kessler, W O Whetsell, M S Ansari, J R Votaw, T de Paulis, J A Clanton, D E Schmidt, N S Mason, R G Mannin. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride. Brain research. vol 609. issue 1-2. 1993-07-15. PMID:8099521. |
the present study demonstrates that dopamine d2 receptors are present in basal ganglia, many limbic regions, cortex and in the thalamus. |
1993-07-15 |
2023-08-12 |
human |
| H Widner, S Rehncron. Transplantation and surgical treatment of parkinsonian syndromes. Current opinion in neurology and neurosurgery. vol 6. issue 3. 1993-07-15. PMID:8507904. |
neurosurgical attempts to correct parkinsonism use strategies aimed either at alleviating the underlying dopamine deficiency or at correcting abnormal compensatory effects in neural circuits within the basal ganglia. |
1993-07-15 |
2023-08-12 |
rat |
| V Laulumaa, J T Kuikka, H Soininen, K Bergström, E Länsimies, P Riekkine. Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123. Archives of neurology. vol 50. issue 5. 1993-06-09. PMID:8489408. |
to test the usefulness of single photon emission computed tomography (spect) with iodobenzamide in imaging basal ganglia and to elucidate the postulated upward regulation of the striatal d2 dopamine receptors in patients with early parkinson's disease. |
1993-06-09 |
2023-08-12 |
Not clear |
| D Hervé, M Lévi-Strauss, I Marey-Semper, C Verney, J P Tassin, J Glowinski, J A Giraul. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 13. issue 5. 1993-05-24. PMID:8478697. |
g(olf) and gs in rat basal ganglia: possible involvement of g(olf) in the coupling of dopamine d1 receptor with adenylyl cyclase. |
1993-05-24 |
2023-08-12 |
rat |
| C Evinger, M A Basso, K A Manning, P A Sibony, J J Pellegrini, A K Hor. A role for the basal ganglia in nicotinic modulation of the blink reflex. Experimental brain research. vol 92. issue 3. 1993-04-21. PMID:8454014. |
three lines of evidence suggest that nicotine affects the blink reflex through the basal ganglia by causing dopamine release in the striatum. |
1993-04-21 |
2023-08-12 |
rat |
| L F Agnati, K Fuxe, F Benfenati, G von Euler, B Fredhol. Intramembrane receptor-receptor interactions: integration of signal transduction pathways in the nervous system. Neurochemistry international. vol 22. issue 3. 1993-04-06. PMID:8382983. |
this review is mainly focused on the evidence for hetero-regulation of dopamine (da) d2 receptors in the basal ganglia. |
1993-04-06 |
2023-08-12 |
Not clear |
| S N Schiffmann, J J Vanderhaeghe. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 13. issue 3. 1993-03-30. PMID:7680065. |
to elucidate at the cellular level the roles of adenosine in the basal ganglia, the anatomical and functional relationships of the a2 receptors with the dopamine d1 and d2 receptors were studied in the rat striatum. |
1993-03-30 |
2023-08-12 |
rat |
| A M Janson, P B Hedlund, M Hillefors, G von Eule. Chronic nicotine treatment decreases dopamine D2 agonist binding in the rat basal ganglia. Neuroreport. vol 3. issue 12. 1993-03-11. PMID:1362898. |
chronic nicotine treatment decreases dopamine d2 agonist binding in the rat basal ganglia. |
1993-03-11 |
2023-08-11 |
rat |
| E Fazzin. Transplantation in the treatment of paralysis agitans (Parkinson's disease). The Journal of the American Osteopathic Association. vol 92. issue 10. 1993-01-08. PMID:1459872. |
it is thought that the mechanism of improvement involves either regenerative sprouting of the remaining dopamine producing neurons as a consequence of the release of neurotrophic factors or an interruption of the striatal pallidal output inhibitory influence of the basal ganglia on the thalamus (or both). |
1993-01-08 |
2023-08-11 |
Not clear |